HH2710
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HH2710, covering 2024-07-19 to 2024-07-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors [Phase 1, Phase 2]